Literature DB >> 28971841

Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.

Ha Won Kim1, Andra L Blomkalns2, Mourad Ogbi1, Manesh Thomas3, Daniel Gavrila3, Bonnie S Neltner4, Lisa A Cassis5, Robert W Thompson6, Robert M Weiss3, Paul D Lindower3, Victor M Blanco4, Michael L McCormick7, Alan Daugherty8, Xiaoming Fu9, Stanley L Hazen9, Brian K Stansfield10, Yuqing Huo11, David J Fulton12, Tapan Chatterjee1, Neal L Weintraub13.   

Abstract

Oxidative stress plays a fundamental role in abdominal aortic aneurysm (AAA) formation. Activated polymorphonuclear leukocytes (or neutrophils) are associated with AAA and express myeloperoxidase (MPO), which promotes inflammation, matrix degradation, and other pathological features of AAA, including enhanced oxidative stress through generation of reactive oxygen species. Both plasma and aortic MPO levels are elevated in patients with AAA, but the role of MPO in AAA pathogenesis has, heretofore, never been investigated. Here, we show that MPO gene deletion attenuates AAA formation in two animal models: ANG II infusion in apolipoprotein E-deficient mice and elastase perfusion in C57BL/6 mice. Oral administration of taurine [1% or 4% (wt/vol) in drinking water], an amino acid known to react rapidly with MPO-generated oxidants like hypochlorous acid, also prevented AAA formation in the ANG II and elastase models as well as the CaCl2 application model of AAA formation while reducing aortic peroxidase activity and aortic protein-bound dityrosine levels, an oxidative cross link formed by MPO. Both MPO gene deletion and taurine supplementation blunted aortic macrophage accumulation, elastin fragmentation, and matrix metalloproteinase activation, key features of AAA pathogenesis. Moreover, MPO gene deletion and taurine administration significantly attenuated the induction of serum amyloid A, which promotes ANG II-induced AAAs. These data implicate MPO in AAA pathogenesis and suggest that studies exploring whether taurine can serve as a potential therapeutic for the prevention or treatment of AAA in patients merit consideration.NEW & NOTEWORTHY Neutrophils are abundant in abdominal aortic aneurysm (AAA), and myeloperoxidase (MPO), prominently expressed in neutrophils, is associated with AAA in humans. This study demonstrates that MPO gene deletion or supplementation with the natural product taurine, which can scavenge MPO-generated oxidants, can prevent AAA formation, suggesting an attractive potential therapeutic strategy for AAA.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  abdominal aortic aneurysm; angiotensin II; calcium chloride; elastase; myeloperoxidase; taurine

Mesh:

Substances:

Year:  2017        PMID: 28971841      PMCID: PMC5814655          DOI: 10.1152/ajpheart.00296.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  47 in total

1.  Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation.

Authors:  Jonathan L Eliason; Kevin K Hannawa; Gorav Ailawadi; Indranil Sinha; John W Ford; Michael P Deogracias; Karen J Roelofs; Derek T Woodrum; Terri L Ennis; Peter K Henke; James C Stanley; Robert W Thompson; Gilbert R Upchurch
Journal:  Circulation       Date:  2005-07-12       Impact factor: 29.690

2.  Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.

Authors:  Nancy R Webb; Maria C De Beer; Joanne M Wroblewski; Ailing Ji; William Bailey; Preetha Shridas; Richard J Charnigo; Victoria P Noffsinger; Jassir Witta; Deborah A Howatt; Anju Balakrishnan; Debra L Rateri; Alan Daugherty; Frederick C De Beer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

3.  3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.

Authors:  S L Hazen; J W Heinecke
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 4.  Myeloperoxidase-generated oxidants and atherosclerosis.

Authors:  E A Podrez; H M Abu-Soud; S L Hazen
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

5.  Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.

Authors:  Joseph A Vita; Marie-Luise Brennan; Noyan Gokce; Shirley A Mann; Marlene Goormastic; Mehdi H Shishehbor; Marc S Penn; John F Keaney; Stanley L Hazen
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

6.  Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Authors:  William F Johnston; Morgan Salmon; Gang Su; Guanyi Lu; Matthew L Stone; Yunge Zhao; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

7.  Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men.

Authors:  C Xiao; A Giacca; G F Lewis
Journal:  Diabetologia       Date:  2007-11-17       Impact factor: 10.122

8.  Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers.

Authors:  F M Fennessy; D S Moneley; J H Wang; C J Kelly; D J Bouchier-Hayes
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 9.  Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery.

Authors:  David C Brewster; Jack L Cronenwett; John W Hallett; K Wayne Johnston; William C Krupski; Jon S Matsumura
Journal:  J Vasc Surg       Date:  2003-05       Impact factor: 4.268

Review 10.  Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease.

Authors:  Michael W Manning; Lisa A Cassi; Jing Huang; Stephen J Szilvassy; Alan Daugherty
Journal:  Vasc Med       Date:  2002-02       Impact factor: 3.239

View more
  21 in total

1.  Copper Transporter ATP7A (Copper-Transporting P-Type ATPase/Menkes ATPase) Limits Vascular Inflammation and Aortic Aneurysm Development: Role of MicroRNA-125b.

Authors:  Varadarajan Sudhahar; Archita Das; Tetsuo Horimatsu; Dipankar Ash; Silvia Leanhart; Olga Antipova; Stefan Vogt; Bhupesh Singla; Gabor Csanyi; Joseph White; Jack H Kaplan; David Fulton; Neal L Weintraub; Ha Won Kim; Masuko Ushio-Fukai; Tohru Fukai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-26       Impact factor: 8.311

2.  Familial Intracranial Aneurysm Requires Not Only Whole-Exome Sequencing, But Also Mitochondrial DNA Sequencing.

Authors:  Josef Finsterer
Journal:  Korean J Radiol       Date:  2022-05       Impact factor: 3.500

3.  Deficiency of immunoglobulin E protects mice from experimental abdominal aortic aneurysms.

Authors:  Jie Li; Zhiyong Deng; Xian Zhang; Feng Liu; Chongzhe Yang; Guo-Ping Shi
Journal:  FASEB J       Date:  2020-01-02       Impact factor: 5.191

Review 4.  Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.

Authors:  Jose Luis Martin-Ventura; Raquel Rodrigues-Diez; Diego Martinez-Lopez; Mercedes Salaices; Luis Miguel Blanco-Colio; Ana M Briones
Journal:  Int J Mol Sci       Date:  2017-11-03       Impact factor: 5.923

5.  Alterations of gut microbiota contribute to the progression of unruptured intracranial aneurysms.

Authors:  Hao Li; Haochen Xu; Youxiang Li; Yuhua Jiang; Yamin Hu; Tingting Liu; Xueqing Tian; Xihai Zhao; Yandong Zhu; Shuxia Wang; Chunrui Zhang; Jing Ge; Xuliang Wang; Hongyan Wen; Congxia Bai; Yingying Sun; Li Song; Yinhui Zhang; Rutai Hui; Jun Cai; Jingzhou Chen
Journal:  Nat Commun       Date:  2020-06-25       Impact factor: 14.919

6.  Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE-/- mice.

Authors:  Zhu Wang; Jingjing Guo; Xinqiang Han; Ming Xue; Wenming Wang; Lei Mi; Yuguo Sheng; Chao Ma; Jian Wu; Xuejun Wu
Journal:  Cell Biosci       Date:  2019-08-27       Impact factor: 7.133

7.  Systems Approach to Study Associations between OxLDL and Abdominal Aortic Aneurysms.

Authors:  Łukasz Gutowski; Kaja Gutowska; Maria Pioruńska-Stolzmann; Piotr Formanowicz; Dorota Formanowicz
Journal:  Int J Mol Sci       Date:  2019-08-11       Impact factor: 5.923

8.  Tropoelastin: an in vivo imaging marker of dysfunctional matrix turnover during abdominal aortic dilation.

Authors:  Begoña Lavin; Sara Lacerda; Marcelo E Andia; Silvia Lorrio; Robert Bakewell; Alberto Smith; Imran Rashid; René M Botnar; Alkystis Phinikaridou
Journal:  Cardiovasc Res       Date:  2020-04-01       Impact factor: 10.787

Review 9.  Antithrombotic therapy in abdominal aortic aneurysm: beneficial or detrimental?

Authors:  Scott J Cameron; Hannah M Russell; A Phillip Owens
Journal:  Blood       Date:  2018-09-18       Impact factor: 25.476

10.  Profiling of Histone Modifications Reveals Epigenomic Dynamics During Abdominal Aortic Aneurysm Formation in Mouse Models.

Authors:  Jacob Greenway; Nicole Gilreath; Sagar Patel; Tetsuo Horimatsu; Mary Moses; David Kim; Lauren Reid; Mourad Ogbi; Yang Shi; Xin-Yun Lu; Mrinal Shukla; Richard Lee; Yuqing Huo; Lufei Young; Ha Won Kim; Neal L Weintraub
Journal:  Front Cardiovasc Med       Date:  2020-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.